We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Oncology

Journal Scan / Research · August 31, 2020

Weekly vs Every-3-Weeks Carboplatin and Paclitaxel in Ovarian Cancer

The Oncologist


Additional Info

Disclosure statements are available on the authors' profiles:

The Oncologist
Weekly Carboplatin and Paclitaxel: A Retrospective Comparison With the Three-Weekly Schedule in First-Line Treatment of Ovarian Cancer
Oncologist 2020 Jul 13;[EPub Ahead of Print], T Safra, B Waissengrin, T Levy, E Leidner, R Merose, D Matceyevsky, D Grisaru, I Laskov, N Mishaan, R Shayzaf, I Wolf

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading